CCNA’s Talking Brains Webinar Series: Staging Alzheimer's Disease In Vivo

For many years, Alzheimer’s disease (AD) was associated with the dementia stage of the disease, the tail end of a pathophysiological process that lasts approximately two decades. Whereas early disease staging systems focused on clinical functioning, brain imaging with positron emission tomography (PET) and cerebrospinal fluid (CSF) biomarker studies highlighted the long preclinical phase of AD. This talk will discuss how the recent proliferation of imaging and fluid AD biomarkers provide an opportunity for the identification of several biological stages in living humans.

Additional Details & Registration